(Q40588264)

English

The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles

scientific article published on January 2004

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Szu-Wen Chen

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Hsu-Chen Chiu

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Wei-Hao Liao

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Fu-Der Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Steve S-L Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Chin-Tien Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

318

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

534-541

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

HIV-1 gag proteins: diverse functions in the virus life cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

Characterization of ribosomal frameshifting in HIV-1 gag-pol expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

Active human immunodeficiency virus protease is required for viral infectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

Deletion of sequences upstream of the proteinase improves the proteolytic processing of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

The dimer interfaces of protease and extra-protease domains influence the activation of protease and the specificity of GagPol cleavage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

Assembly and processing of human immunodeficiency virus Gag mutants containing a partial replacement of the matrix domain by the viral protease domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

Form, function, and use of retroviral gag proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Standardized and simplified nomenclature for proteins common to all retroviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.08.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2003.08.043

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40588264&oldid=1903269789"